Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KLIJN, J. G. M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 158

  • Page / 7

Export

Selection :

  • and

Hormonal manipulation of cancer : peptides, growth factors and new (anti) stroidal agents : abstracts, Rotterdam, The Netherlands, 9,10-11 April 1990KLIJN, J. G. M; PARIDAENS, R.European journal of cancer & clinical oncology. 1990, Vol 26, Num 2, pp 143-197, issn 0277-5379Conference Paper

Gene screening and prevention of hereditary breast cancer: a clinical viewKLIJN, J. G. M; MEIJERS-HEIJBOER, H.European journal of cancer. Supplement (1990). 2003, Vol 1, Num 1, pp 13-23, issn 1359-6349, 11 p.Article

LHRH-agonist versus chemotherapy in premenopausal breast cancer?KLIJN, J. G. M.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 6, pp S45-S46, issn 1359-6349Conference Paper

Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cellsBLANKENSTEIN, M. A; HENKELMAN, M. S; KLIJN, J. G. M et al.European journal of cancer & clinical oncology. 1985, Vol 21, Num 12, pp 1493-1499, issn 0277-5379Article

Effects of the progesterone antagonist RU486 on ovarian activity in the ratVAN DER SCHOOT, P; BAKKER, G. H; KLIJN, J. G. M et al.Endocrinology (Philadelphia). 1987, Vol 121, Num 4, pp 1375-1382, issn 0013-7227Article

Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?BRESSER, P. J. C; VAN GOOL, A. R; SEYNAEVE, C et al.Annals of oncology. 2007, Vol 18, Num 10, pp 1641-1645, issn 0923-7534, 5 p.Article

Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testingVAN OOSTROM, I; MEIJERS-HEIJBOER, H; DUIVENVOORDEN, H. J et al.Annals of oncology. 2006, Vol 17, Num 7, pp 1090-1095, issn 0923-7534, 6 p.Article

Cancer risks in BRCA2 families : estimates for sites other than breast and ovaryVAN ASPEREN, C. J; BROHET, R. M; HOGERVORST, F. B. L et al.Journal of medical genetics. 2005, Vol 42, Num 9, pp 711-719, issn 0022-2593, 9 p.Article

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variantDE BOCK, G. H; SCHUTTE, M; TOLLENAAR, R. A. E. M et al.Journal of medical genetics. 2004, Vol 41, Num 10, pp 731-735, issn 0022-2593, 5 p.Article

Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer : A European organization for research and treatment of cancer randomized study with cross-overPARIDAENS, R; BIGANZOLI, L; AWADA, A et al.Journal of clinical oncology. 2000, Vol 18, Num 4, pp 724-733, issn 0732-183XArticle

Value of estrogenic recruitment before chemotherapy : First randomized trial in primary breast cancerBONTENBAL, M; VAN PUTTEN, W. L. J; VAN DER VELDEN, P. C et al.Journal of clinical oncology. 2000, Vol 18, Num 4, pp 734-742, issn 0732-183XArticle

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancerBERNS, E. M. J. J; FOEKENS, J. A; CORNELISSE, C et al.Cancer research (Baltimore). 2000, Vol 60, Num 8, pp 2155-2162, issn 0008-5472Article

Cathepsin-D in primary breast cancer : prognostic evaluation involving 2810 patientsFOEKENS, J. A; LOOK, M. P; BOLT-DE VRIES, J et al.British journal of cancer. 1999, Vol 79, Num 2, pp 300-307, issn 0007-0920Article

Family history of breast cancer and local recurrence after breast-conserving therapyBREKELMANS, C. T. M; VOOGD, A. C; BOTKE, G et al.European journal of cancer (1990). 1999, Vol 35, Num 4, pp 620-626, issn 0959-8049Article

Urokinase-type-plasminogen-activator(UPA) production by human breast (myo)fibroblasts in vitro : Influence of transforming growth FACTOR-β1 (TGFβ1) compared with factor(s) released by human epithelial-carcinoma cellsSIEUWERTS, A. M; KLIJN, J. G. M; HENZEN-LOGMANS, S. C et al.International journal of cancer. 1998, Vol 76, Num 6, pp 829-835, issn 0020-7136Article

Effects of progestagens and Org OD14 in in vitro and in vivo tumor modelsKLOOSTERBOER, H. J; SCHOONEN, W. G. E. J; DECKERS, G. H et al.Journal of steroid biochemistry and molecular biology. 1994, Vol 49, Num 4-6, pp 311-318, issn 0960-0760Conference Paper

Effects of orchiectomy, alone or in combination with testosterone, and cyproterone acetate on exocrine pancreatic carcinogenesis in rats and hamstersMEIJERS, M; VISSER, C. J. T; KLIJN, J. G. M et al.International journal of pancreatology. 1992, Vol 11, Num 2, pp 137-146, issn 0169-4197Article

Effects of sandostatin and castration on pancreatic carcinogenesis in rats and hamstersMEIJERS, M; WOUTERSEN, R. A; VAN GARDEREN-HOETMER, A et al.International journal of cancer. 1992, Vol 50, Num 2, pp 246-251, issn 0020-7136Article

The somatostatin analog Sandostatin (SMS201-995) in treatment of DMBA-induced rat mammary tumorsBAKKER, G. H; SETYONO-HAN, B; FOEKENS, J. A et al.Breast cancer research and treatment. 1990, Vol 17, Num 1, pp 23-32, issn 0167-6806, 10 p.Article

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue sandostatin : a phase II study including endocrine effectsKLIJN, J. G. M; HOFF, A. M; PLANTING, A. S. T et al.British journal of cancer. 1990, Vol 62, Num 4, pp 627-630, issn 0007-0920, 4 p.Article

Uterine radiation dose from open sources : the potential for underestimationCOX, P. H; KLIJN, J. G. M; PILLAY, M et al.European journal of nuclear medicine. 1990, Vol 17, Num 1-2, pp 94-95, issn 0340-6997Article

Antiprogestins, a new form of endocrine therapy for human breast cancerKLIJN, J. G. M; DE JONG, F. H; BAKKER, G. H et al.Cancer research (Baltimore). 1989, Vol 49, Num 11, pp 2851-2856, issn 0008-5472Article

Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumorsBAKKER, G. H; SETYONO-HAN, B; PORTENGEN, H et al.Endocrinology (Philadelphia). 1989, Vol 125, Num 3, pp 1593-1598, issn 0013-7227Article

LHRH-agonist treatment in metastatic prostate carcinoma = Traitement des cancers prostatiques par les agonistes de la LH-RHKLIJN, J. G. M; DE JONG, F. H; LAMBERTS, S. W. J et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 4, pp 483-493, issn 0277-5379Article

Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancerKRIEGE, M; BREKELMANS, C. T. M; TILANUS-LINTHORST, M. M. A et al.Breast cancer research and treatment. 2007, Vol 102, Num 3, pp 357-363, issn 0167-6806, 7 p.Article

  • Page / 7